1. Home
  2. SQFT vs ADXN Comparison

SQFT vs ADXN Comparison

Compare SQFT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SQFT
  • ADXN
  • Stock Information
  • Founded
  • SQFT 1999
  • ADXN 2002
  • Country
  • SQFT United States
  • ADXN Switzerland
  • Employees
  • SQFT N/A
  • ADXN N/A
  • Industry
  • SQFT Real Estate Investment Trusts
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SQFT Real Estate
  • ADXN Health Care
  • Exchange
  • SQFT Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • SQFT 8.3M
  • ADXN 8.0M
  • IPO Year
  • SQFT 2020
  • ADXN N/A
  • Fundamental
  • Price
  • SQFT $0.66
  • ADXN $7.36
  • Analyst Decision
  • SQFT
  • ADXN Strong Buy
  • Analyst Count
  • SQFT 0
  • ADXN 1
  • Target Price
  • SQFT N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • SQFT 26.2K
  • ADXN 15.1K
  • Earning Date
  • SQFT 02-25-2025
  • ADXN 03-24-2025
  • Dividend Yield
  • SQFT N/A
  • ADXN N/A
  • EPS Growth
  • SQFT N/A
  • ADXN N/A
  • EPS
  • SQFT N/A
  • ADXN 0.06
  • Revenue
  • SQFT $18,586,052.00
  • ADXN $701,260.00
  • Revenue This Year
  • SQFT N/A
  • ADXN N/A
  • Revenue Next Year
  • SQFT N/A
  • ADXN N/A
  • P/E Ratio
  • SQFT N/A
  • ADXN $1.01
  • Revenue Growth
  • SQFT 5.44
  • ADXN N/A
  • 52 Week Low
  • SQFT $0.47
  • ADXN $6.73
  • 52 Week High
  • SQFT $1.39
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • SQFT 46.88
  • ADXN 46.90
  • Support Level
  • SQFT $0.54
  • ADXN $6.73
  • Resistance Level
  • SQFT $0.72
  • ADXN $7.90
  • Average True Range (ATR)
  • SQFT 0.05
  • ADXN 0.38
  • MACD
  • SQFT -0.00
  • ADXN -0.05
  • Stochastic Oscillator
  • SQFT 64.86
  • ADXN 39.55

About SQFT Presidio Property Trust Inc.

Presidio Property Trust Inc is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. The office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: